f.achebe
Submits third-party assay reports on material purchased directly. Based in Odense.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.54%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041668 | PT-141 (Bremelanotide) | FGP | FGP-2602-Y8741 | PeptideMeter | 2026-Q2 | 99.59 | 4.86 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018631 | Tirzepatide | QSC | QSC-2502-P5432 | Janoshik | 2025-Q3 | 98.55 | 2.54 | 97.8 | Buyer-sourced | 0 | PASS |
| AX-2025-019245 | CJC-1295 (no DAC) | AMB | AMB-2507-S5238 | Janoshik | 2025-Q3 | 99.66 | 6.34 | 103.5 | Buyer-sourced | 0 | PASS |
| AX-2025-021153 | Ipamorelin | PPG | PPG-2505-U7155 | Janoshik | 2025-Q2 | 99.66 | 4.85 | 89.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020758 | Semaglutide | SGN | SGN-2502-J9369 | Medutest | 2025-Q2 | 97.71 | 5.63 | 95.9 | Buyer-sourced | 2 | FAIL |
| AX-2025-019812 | Semaglutide | Homopeptide | HOMO-2501-A5192 | Medutest | 2025-Q2 | 99.90 | 6.45 | 89.5 | Laboratory-retained | 1 | MARGINAL |
| AX-2024-005032 | TB-500 | KP | KP-2407-V6115 | Janoshik | 2024-Q4 | 99.54 | 3.95 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005165 | N-Acetyl Semax Amide | SGN | SGN-2407-R9375 | VendorInvestigate | 2024-Q3 | 98.74 | 8.31 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2024-005258 | Semaglutide | BCH | BCH-2405-U4366 | Medutest | 2024-Q2 | 97.75 | 4.15 | 104.1 | Buyer-sourced | 0 | PASS |